Create Alert
Watchlist

Cohance Lifesciences

₹899.35
-2.30 (0.26%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
904.00
Prev. Close
901.65
Volume
10,24,318
Total traded value
92.12 Cr
Upper Circuit
1,081.95
Lower Circuit
721.35

Fundamentals

Market Cap₹34,498Cr
ROE28.72%
P/E Ratio(TTM)103.18
EPS(TTM)8.74
P/B Ratio20.18
Dividend Yield0.00%
Industry P/E35.77
Book Value44.68
Debt to Equity0.16
Face Value1
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Cohance Lifesciences

Suven Pharma is a contract development and manufacturing (CDMO) company providing services to global pharmaceutical and fine chemical innovators from research to commercial production. Its core principle is to consistently deliver on commitments, which has enabled its transformation from a domestic player to a global partner for major brands. The company has an excellent track record, having delivered more than 900 CDMO projects on time to its global clients.;
Parent OrganisationCohance Lifesciences
Managing DirectorDr. Vetukuri Venkata Prasada Raju
NSE SymbolCOHANCE

Shareholding Pattern

Sep '24
Dec '24
Mar '25
May '25
Jun '25
Promoters
66.41%
Retail And Others
14.96%
Mutual Funds
8.90%
Foreign Institutions
7.23%
Other Domestic Institutions
2.50%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.33
Emcure Pharmaceuticals
NA
(0.00%)
33.60
Wockhardt
NA
(0.00%)
-195.86
Concord Biotech
NA
(0.00%)
47.62